Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Aaron Bianco

Orthopaedic Surgery of the Spine Syracuse, NY Medical Doctor

NPI 1871756783 CMS profile 130857

5719 Widewaters Pkwy, Syracuse, NY 13214

Open in the dashboard

General payments

$49,312

207 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Aaron Bianco of Syracuse, NY is reported in the CMS Open Payments database as having received $49,312 across 207 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 69th percentile of Orthopaedic Surgery of the Spine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $14,597 19
2024 General $11,101 23
2023 General $2,556 32
2022 General $17,976 39
2021 General $1,524 40
2020 General $585 25
2019 General $972 29

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Aaron Bianco
  • Orthopaedic Surgery of the Spine median
  • Middle half of Orthopaedic Surgery of the Spine
  • National median

In program year 2025, general payments to Aaron Bianco were reported at $14,597. Among 1,704 Orthopaedic Surgery of the Spine profiles paid that year, the median was $2,061 and the middle half received between $347 and $14,651.

Show as a table
Year Aaron Bianco Orthopaedic Surgery of the Spine median Middle half National median
2019 $972 $2,106 $337–$18,608 $163
2020 $585 $1,213 $156–$15,082 $114
2021 $1,524 $1,834 $271–$15,617 $132
2022 $17,976 $2,015 $320–$17,036 $149
2023 $2,556 $1,925 $336–$14,599 $160
2024 $11,101 $2,110 $341–$12,483 $164
2025 $14,597 $2,061 $347–$14,651 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. SI-BONE, Inc. $26,638 60 payments
  2. OrthoFundamentals, LLC $16,515 5 payments
  3. Alphatec Spine, Inc $2,157 18 payments
  4. Stryker Corporation $1,220 16 payments
  5. Medtronic, Inc. $1,015 53 payments
  6. Globus Medical, Inc. $749 20 payments
  7. Smith+Nephew, Inc. $523 6 payments
  8. Medtronic USA, Inc. $267 22 payments
  9. Ethicon US, LLC $113 1 payment
  10. Integra LifeSciences Corporation $46 2 payments
  11. Other $70 4 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $22,950 7 payments
  2. Royalty or License $16,515 5 payments
  3. Food and Beverage $8,298 186 payments
  4. Travel and Lodging $1,549 9 payments
Products named General payments · program years 2019–2025
  1. IFUSE IMPLANT $17,451 35 payments
  2. IFUSE IMPLANT SYSTEM $7,607 5 payments
  3. Trellis SI Joint Fusion System $6,333 2 payments
  4. Other - Miscellaneous $831 5 payments
  5. CATALYFT PL EXPANDABLE INTERBODY SYSTEM $487 23 payments
  6. LIF $448 3 payments
  7. TRIGEN INTERTAN $399 4 payments
  8. ALEUTIAN INTERBODY SYSTEMS $334 2 payments
  9. XIA $208 3 payments
  10. EVOS $184 3 payments
  11. Other $3,195 110 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 8 drugs

Part D claims

232

Median for Orthopedic Surgery: 203

Drug cost

$1,770

Median for Orthopedic Surgery: $1,433

Branded share of claims

11.6%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 52 $611
Methylprednisolone Generic 46 $251
Ibuprofen Generic 19 $217
Cyclobenzaprine Hcl Generic 16 $177
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 27 $166
Naproxen Generic 12 $151
Oxycodone Hcl Generic 22 $127
Meloxicam Generic 38 $69

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 65 billing codes

Paid by Medicare

$141,057

Of which drugs: $116

Medicare patients

321

Average age 72

Services billed

2,078

192 women, 129 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 26%
Ischemic heart disease 22%
Depression 22%
Chronic kidney disease 20%
COPD 19%
Osteoporosis 18%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, methylprednisolone acetate, 1 mg J1010 Office 14 1,200 $108

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

207 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery of the Spine in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record